Cargando…

The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis

BACKGROUND: Contrast-induced nephropathy (CIN) is the main complication of contrast media administration (CM) in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). There are inconsistent results in the literature regarding the effect of renin-angiotensin-ald...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhijun, Zhang, Huan, Jin, Wei, Liu, Yan, Lu, Lin, Chen, Qiujing, Zhang, Ruiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470628/
https://www.ncbi.nlm.nih.gov/pubmed/26083525
http://dx.doi.org/10.1371/journal.pone.0129747
_version_ 1782376789743501312
author Wu, Zhijun
Zhang, Huan
Jin, Wei
Liu, Yan
Lu, Lin
Chen, Qiujing
Zhang, Ruiyan
author_facet Wu, Zhijun
Zhang, Huan
Jin, Wei
Liu, Yan
Lu, Lin
Chen, Qiujing
Zhang, Ruiyan
author_sort Wu, Zhijun
collection PubMed
description BACKGROUND: Contrast-induced nephropathy (CIN) is the main complication of contrast media administration (CM) in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). There are inconsistent results in the literature regarding the effect of renin-angiotensin-aldosterone system (RAAS) blockers (angiotensin-converting enzyme inhibitors [ACEIs] and angiotensin receptor blockers [ARBs]) on CIN. We evaluated the association between the administration of ACEI/ARBs and CIN, as well as the effect of ACEI/ARBs on post-procedural changes in renal function index, in patients undergoing CAG. METHODS: We searched Pubmed, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for relevant studies. The primary search generated 893 potentially relevant articles. A total of 879 studies were excluded because they did not meet the selection criteria. Finally, 14 studies were eligible for inclusion. There were 7,288 patients that received ACEI/ARBs and 8,159 patients that received placebo or naive to ACEI/ARBs in the study. A random or a fixed effect model was used to calculate the pooled odd ratios (ORs). RESULTS: The risk of CIN was significantly increased in the ACEI/ARBs group compared to the control group (OR= 1.50, 95%CI: 1.03-2.18, P =0.03). The magnitude of association was significantly reinforced in the observational studies (OR=1.84, 95%CI 1.19-2.85, P=0.006) but not in the randomized controlled trials (OR=0.88, 95%CI 0.41-1.90 P=0.74). The summary adjusted OR of 4 observational studies was 1.56 (95%CI 1.25-1.94, P<0.0001) and was weaker than the unadjusted OR. CONCLUSIONS: Although there is some evidence to suggest that the administration of RAAS blockers was associated with the increased risk of CIN in patients undergoing CAG, the robustness of our study remains weak. The results are based on small observational studies and need further validation.
format Online
Article
Text
id pubmed-4470628
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44706282015-06-29 The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis Wu, Zhijun Zhang, Huan Jin, Wei Liu, Yan Lu, Lin Chen, Qiujing Zhang, Ruiyan PLoS One Research Article BACKGROUND: Contrast-induced nephropathy (CIN) is the main complication of contrast media administration (CM) in patients undergoing coronary angiography (CAG) and percutaneous coronary intervention (PCI). There are inconsistent results in the literature regarding the effect of renin-angiotensin-aldosterone system (RAAS) blockers (angiotensin-converting enzyme inhibitors [ACEIs] and angiotensin receptor blockers [ARBs]) on CIN. We evaluated the association between the administration of ACEI/ARBs and CIN, as well as the effect of ACEI/ARBs on post-procedural changes in renal function index, in patients undergoing CAG. METHODS: We searched Pubmed, EMBASE, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov for relevant studies. The primary search generated 893 potentially relevant articles. A total of 879 studies were excluded because they did not meet the selection criteria. Finally, 14 studies were eligible for inclusion. There were 7,288 patients that received ACEI/ARBs and 8,159 patients that received placebo or naive to ACEI/ARBs in the study. A random or a fixed effect model was used to calculate the pooled odd ratios (ORs). RESULTS: The risk of CIN was significantly increased in the ACEI/ARBs group compared to the control group (OR= 1.50, 95%CI: 1.03-2.18, P =0.03). The magnitude of association was significantly reinforced in the observational studies (OR=1.84, 95%CI 1.19-2.85, P=0.006) but not in the randomized controlled trials (OR=0.88, 95%CI 0.41-1.90 P=0.74). The summary adjusted OR of 4 observational studies was 1.56 (95%CI 1.25-1.94, P<0.0001) and was weaker than the unadjusted OR. CONCLUSIONS: Although there is some evidence to suggest that the administration of RAAS blockers was associated with the increased risk of CIN in patients undergoing CAG, the robustness of our study remains weak. The results are based on small observational studies and need further validation. Public Library of Science 2015-06-17 /pmc/articles/PMC4470628/ /pubmed/26083525 http://dx.doi.org/10.1371/journal.pone.0129747 Text en © 2015 Wu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wu, Zhijun
Zhang, Huan
Jin, Wei
Liu, Yan
Lu, Lin
Chen, Qiujing
Zhang, Ruiyan
The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title_full The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title_fullStr The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title_full_unstemmed The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title_short The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis
title_sort effect of renin-angiotensin-aldosterone system blockade medications on contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470628/
https://www.ncbi.nlm.nih.gov/pubmed/26083525
http://dx.doi.org/10.1371/journal.pone.0129747
work_keys_str_mv AT wuzhijun theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT zhanghuan theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT jinwei theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT liuyan theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT lulin theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT chenqiujing theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT zhangruiyan theeffectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT wuzhijun effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT zhanghuan effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT jinwei effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT liuyan effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT lulin effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT chenqiujing effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis
AT zhangruiyan effectofreninangiotensinaldosteronesystemblockademedicationsoncontrastinducednephropathyinpatientsundergoingcoronaryangiographyametaanalysis